发明名称 Preparation of anhydrous and hydrated polymorphs 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-YL)-1H-benzimidazol-2-YL]-1H-quinolin-2-one-lactic acid salt
摘要 The present technology provides methods of making anhydrous crystalline Form II and monohydrate crystalline Form B of the lactic acid salt of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one.
申请公布号 US8987448(B2) 申请公布日期 2015.03.24
申请号 US201113637048 申请日期 2011.03.25
申请人 Novartis AG 发明人 Grandeury Arnaud;Riegert Christian;Schreiner Andreas
分类号 C07D401/04 主分类号 C07D401/04
代理机构 代理人 Ferraro Gregory
主权项 1. A method of making Form B, a monohydrate crystalline form of a lactic acid salt of a compound of formula I, comprising: heating to a temperature ranging from 50 to 70° C. a suspension of the free base of the compound of formula I or a polymorphic form or a mixture of polymorphs of the lactic acid salt of compound of formula I and lactic acid in a solution comprising at least two solvents and a water activity of about 0.3 to about 0.6; and, isolating crystals of at least 90% pure form B from the solution at a temperature ranging from 50 to 60° C., wherein the CuKα XRPD pattern for the Form B has 2Θ peaks at 7.6°, 11.8°, 12.8°, 15.3°, 16.1°, 17.5°, 18.4°, 19.24°, 23.2°, 23.4°, 25.9°, 28.0°, 29.2° and 29.8°±0.2°, respectively.
地址 Basel CH